[1]赵勇 李涛.恶性肿瘤引起输尿管梗阻的外科治疗进展[J].中华腔镜泌尿外科杂志(电子版),2015,(02):146-150.[doi:10.3877/cma.j.issn.1674-3253.2015.02.019 ]
点击复制

恶性肿瘤引起输尿管梗阻的外科治疗进展()
分享到:

中华腔镜泌尿外科杂志(电子版)[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2015年02期
页码:
146-150
栏目:
·综述·
出版日期:
2015-08-31

文章信息/Info

作者:
赵勇 李涛
350000 福建福州福建中医药大学,福建省立医院
关键词:
恶性肿瘤输尿管梗阻金属支架经皮肾穿刺造瘘肾盂膀胱皮下分流术
DOI:
10.3877/cma.j.issn.1674-3253.2015.02.019
摘要:
恶性肿瘤引起的输尿管梗阻发病率逐年增加,此类患者常常寿命较短。在治疗此类患者之前,必须考虑到患者生活质量的问题。治疗的目标是解除输尿管梗阻,避免泌尿系统的并发症及提供患者继续治疗原发肿瘤的机会。经皮肾穿刺造瘘术虽然可以良好地引流尿液,但术后降低了患者的生活质量。鉴于患者身体情况,复杂的手术亦不适合用于解除此类梗阻。随着技术及材料的进步,各种金属支架及新型输尿管支架被应用于临床,与聚合物支架管相比,减少了并发症并延长支架管更换间隔时间。肾盂膀胱尿液分流术也可以很好的缓解此类梗阻并且术后患者生活质量较高。

参考文献/References:

[1]陈昭典,韦思明,蔡松良.急性上尿路梗阻性无尿应注意的临床问题[J].中华外科杂志, 2004, 42(1): 55-57. [2]吴志平,石家齐,由慧娟 .输尿管镜双 J管置入治疗放疗后输尿管梗阻 9例[J].中国医师进修杂志:外科版, 2006, 29(2): 49, 51. [3]马永江主编吴阶平.实用泌尿外科学 [M].北京市 :人民军医出版社, 1991. [4]沈瑞林 ,蔡松良 .急性上尿路梗阻性无尿的治疗方法探讨(附 58例报告) [J].临床泌尿外科杂志, 2007, 22(3): 192-194. [5]刘永达,袁坚.输尿管镜术后双 J管引流无效原因分析[J].中华泌尿外科杂志, 2004, 25(10): 694-696. [6] Ku JH, Lee SW, Jeon HG, et al. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences [J]? Urology, 2004, 64(5): 895-899. [7] Chitale SV, Scott-Barrett S, Ho ETS, et al. The management of ureteric obstruction secondary to malignant pelvic disease[J]. Clin Radiol, 2002, 57(12):1118-1121. [8] Feng MI, Bellman GC, Shapiro CE. Management of ureteral obstruction secondary to pelvic malignancies[J]. J Endourol, 1999, 13(7): 521-524. [9] Lu DSK, Papanicolaou N, Girard M, et al. Percutaneous internal ureteral stent placement: review of technical issues and solutions in 50 consecutive cases[J]. Clin Radiol, 1994, 49(4): 256-261. [10] Watson G. Problems with double-J stents and nephrostomy tubes[J]. J Endourol, 1997, 11(6): 413-417. [11] Macri A, Magno C, Certo A, et al. Combined antegrade and retrograde ureteral stenting: the rendezvous technique [J]. Clin Radiol, 2005, 60(2): 257-260. [12] Yossepowitch O, Lifshitz DA, Dekel Y, et al. Predicting the success of retrograde stenting for managing ureteral obstruction[J]. J Urol, 2001, 166(5): 1746-1749. [13] Cormio L, La Forgia P, La Forgia D, et al. Is it possible to prevent bacterial adhesion onto ureteric stents[J] ?Urol Res, 1997, 25(3): 213-216. [14] Liatsikos EN, Karnabatidis D, Kagadis GC, et al. Application of paclitaxel-eluting metal mesh stents within the pig ureter: an experimental study[J]. Eur Urol, 2007, 51(1): 217-223. [15]李逊 ,吴开俊 .金属网状支架在治疗上尿路闭锁中的应用 [J].中华泌尿外科杂志, 2000, 21(5): 299-300. [16] Chung KJ, Park BH, Park B, et al. Efficacy and safety of a novel, double-layered, coated, self-expandable metallic mesh stent (Uventa) in malignant ureteral obstructions [J]. J Endourol, 2013, 27(7): 930-935. [17] Kim JH, Song K, Jo MK, et al. Palliative care of malignant ureteral obstruction with polytetrafluoroethylene membrane-covered self-expandable metallic stents: initial experience[J]. Korean J Urol, 2012, 53(9): 625-631. [18]黄贵良 .自扩张金属支架治疗恶性输尿管阻塞的近期效果 [J].国外医学(临床放射学分册), 1994, (3):185. [19] Sountoulides P, Kaplan A, Kaufmann OG, et al. Current status of metal stents for managing malignant ureteric obstruction [J]. BJU Int, 2010, 105(8): 1066-1072. [20] Agrawal S, Brown CT, Bellamy EA, et al. The thermo-expandable metallic ureteric stent: an 11-year follow-up [J]. BJU Int, 2009, 103(3): 372-376. [21] Maan Z, Patel D, Moraitis K, et al. Comparison of stent-related symptoms between conventional Double-J stents and a new-generation thermoexpandable segmental metallic stent: a validated-questionnaire-based study [J]. J Endourol, 2010, 24(4): 589-593. [22] Zaman F, Poullis C, Bach C, et al. Use of a segmental thermoexpandable metal alloy stent in the management of malignant ureteric obstruction: a single centre experience in the UK[J]. Urol Int,2011, 87(4): 405-410. [23] Chow PM, Hsu JS, Wang SM, et al. Metallic ureteral stents in malignant ureteral obstruction: short-term results and radiological features predicting stent failure in patients with non-urological malignancies[J]. World J Urol, 2013, [Epub ahead of print]. [24] Taylor ER, Benson AD, Schwartz BF. Cost analysis of metallic ureteral stents with 12 months of follow-up [J]. J Endourol, 2012, 26(7):917-921. [25] Goldsmith ZG, Wang AJ, Banez LL, et al. Outcomes of metallic stents for malignant ureteral obstruction [J]. J Urol, 2012, 188(3): 851-855. [26] Soria F, Rioja LA, Morcillo E, et al. New combined approach in metallic ureteral stenting to avoid urothelial hyperplasia: study in swine model[J]. J Urol, 2011, 185(5): 1939-1945. [27] Brown JA, Powell CL, Carlson KR. Metallic full-length ureteral stents: does urinary tract infection cause obstruction [J]? ScientificWorldJournal, 2010, 10(17): 1566-1573. [28] Chung HH, Lee SH, Cho SB, et al. Comparison of a new polytetrafluoroethylene-covered metallic stent to a noncovered stent in canine ureters [J]. Cardiovasc Intervent Radiol, 2008, 31 (3):619-628. [29] Barbalias GA, Liatsikos EN, Kalogeropoulou C, et al. Externally coated ureteral metallic stents : an unfavorable clinical experience [J]. Eur Urol, 2002, 42(3): 276-280. [30] Chitale SV, Webb RJ. Ureteric stenting for repair of accidental ureteric injuries[J]. Ann R Coll Surg Engl, 2001, 83(4):244-245. [31]林云琴 ,章灵芝 ,苏燕 ,等.永久性肾造瘘患者造瘘管最佳更换时间的循证护理分析 [J].中国基层医药 , 2010, (16): 2295-2296. [32] Wah TM, Weston MJ, Irving HC. Percutaneous nephrostomy insertion: outcome data from a prospective multi-operator study at a UK training centre[J]. Clin Radiol, 2004, 59(3): 255-261. [33] Hausegger KA, Portugaller HR. Percutaneous nephrostomy and antegrade ureteral stenting: technique-indications-complications[J]. Eur Radiol, 2006, 16(9): 2016-2030. [34] Chung SY, Stein RJ, Landsittel D, et al. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents[J]. J Urol, 2004, 172(2): 592-595. [35]王恒兵 ,庄海军 ,杨晓松 ,等.经皮下肾盂膀胱分流术在输尿管梗阻患者中的应用[J].实用医学杂志, 2012, 28(15): 2646-2647. [36] Desgrandchamps F, Leroux S, Ravery V, et al. Subcutaneous pyelovesical bypass as replacement for standard percutaneous nephrostomy for palliative urinary diversion : prospective evaluation of patient's quality of life[J]. J Endourol,2007, 21(2): 173-176. [37]张弋 ,崔昕 ,史沛清 ,等.肾盂膀胱皮下分流治疗不可恢复的输尿管梗阻致严重肾积水 [J].中华外科杂志 , 2010, 48(18): 1437-1438. [38] Schmidbauer J, Kratzik C, Klingler HC, et al. Nephrovesical subcutaneous ureteric bypass: long-term results in patients with advanced metastatic disease-improvement of renal function and quality of life[J]. Eur Urol, 2006, 50(5): 1073-1078. [39] Nissenkorn I, Gdor Y. Nephrovesical subcutaneous stent: an alternative to permanent nephrostomy [J]. J Urol, 2000, 163(2): 528-530. [40]陈明 ,陈恕求 ,柳靖 ,等.肾盂膀胱皮下输尿管旁路术治疗晚期肿瘤的输尿管梗阻[J].江苏医药, 2011, 37(23): 2768-2770. [41] Jabbour ME, Desgrandchamps F, Angelescu E, et al. Percutaneous implantation of subcutaneous prosthetic ureters: long-term outcome[J]. J Endourol, 2001, 15(6): 611-614. [42] Lev-Chelouche D, Keidar A, Rub R, et al. Hydronephrosis associated with colorectal carcinoma: treatment and outcome [J]. Eur J Surg Oncol, 2001, 27(5): 482-486.

相似文献/References:

[1]陈云清,梁华良,黄芳伟,等.膀胱镜下双J管置入术治疗肿瘤转移与浸润相关性输尿管梗阻的疗效探讨[J].中华腔镜泌尿外科杂志(电子版),2010,(04):316.
 CHEN Yun-qing,LIANG Hua-liang,HUANG Fang-wei,et al.Effective investigation of cystoscopic ureteral stent placement for the treatment of ureteral obstruction related with cancer metastasis and infiltration (report of 10 cases).[J].,2010,(02):316.
[2]赵亮,王长希,王文卫,等.顺行球囊扩张治疗移植肾输尿管梗阻:附4例报告[J].中华腔镜泌尿外科杂志(电子版),2011,(03):218.
 ZHAO Liang,WANG Chang-xi,WANG Wen-wei,et al.The treatment of antegrade balloon dilation for ureteral obstruction in transplant kidney: 4 cases report[J].,2011,(02):218.
[3]瞿虎 马波 汪中扬 张靖 袁浩锋.恶性肿瘤致输尿管梗阻治疗方法的选择及疗效观察[J].中华腔镜泌尿外科杂志(电子版),2014,(06):437.[doi:10.3877/cma.j.issn.1674-3253.2014.06.010 ]
 Qu Hu,Ma Bo,Wang Zhongyang,et al.Clinical effectiveness of the treatments for ureteral obstruction caused by malignant tumor[J].,2014,(02):437.[doi:10.3877/cma.j.issn.1674-3253.2014.06.010 ]

备注/Memo

备注/Memo:
通讯作者:李涛,Email: cnfjtony@163.com
更新日期/Last Update: 1900-01-01